Spinal Tech

Orthopeutics Wins Patent for Injectable Treatment of Spinal Discs

Orthopeutics will soon be awarded its seventh U.S. patent covering NEXT, an injectable treatment to repair spinal discs and other soft tissue disorders.

Jaimie Oh

Wednesday, October 10th, 2012

The latest patent addresses reagent formulations for Orthopeutics’ injectable tissue-repair products. Orthopeutics has commenced the human clinical trials phase of NEXT for degenerative disc disease, engaging multiple clinical specialties to validate their custom injection-delivery protocol, with overseas first-in-man trials beginning soon.

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

AI in spine care has been commonly leveraged to support administrative tasks, but one of its real potentials lies in…

By: Carly Behm
Wednesday, November 19th, 2025
Stryker net sales up 10.3% in Q3: 5 notes

Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.…

By: Ariana Portalatin
Friday, October 31st, 2025
4 spine FDA nods in October

Here are four companies earning FDA clearance for spine technology this month: 1. Elevation Spine’s Saber-C earned FDA clearance for…

By: Ariana Portalatin
Friday, October 31st, 2025

Comments are closed.

More Articles on Orthopedic Devices:

How specialty pharmacies are speeding approvals + reducing staff friction

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

Stryker net sales up 10.3% in Q3: 5 notes

4 spine FDA nods in October

Join the spine leaders & surgeons who start their day with Becker's